Brad Loncar

Brad Loncar is the founder of BiotechTV, an independent media outlet that provides industry and company news, educational videos, and behind-the-scenes tours of the biotechnology industry. Since launching in June 2023, BiotechTV has grown in its scale and reach, now having three regional correspondents in San Diego, Philadelphia, and the United Kingdom and expanding the outlet’s regular shows to include BioVenture VoiCes, Biotech CEO Sisterhood, The Studio at Kendall Square, and Off-Target Effects.
Prior to launching BiotechTV, Brad was an independent biotech investor and analyst, managing a biotech-focused family office.
Through Loncar Investments LLC, he used his research of biotech companies and technologies to develop thematic biotech investment indexes, and he was the creator of two Nasdaq listed exchange traded funds.
Brad previously worked at Franklin Templeton Investments and served in a Senior Advisor role at the U.S. Department of the Treasury. Brad is one of the most followed biotech commentators on social media and regularly offers his own commentary on trending topics on X, formerly Twitter. He holds a BA in Finance from the University of Miami.
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
Sponsor Spotlight
At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.